The Use of Liposomal Bupivacaine in TAP Blocks for Women Undergoing Cesarean Section
Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This present investigation aims to determine whether a transversus abdominous plane(TAP)
block, utilizing liposomal bupivacaine (Exparel), at the conclusion of a cesarean section
decreases post-operative pain. The hypothesis is that performance of the TAP block with
liposomal bupivacaine will decrease post-operative narcotic use.